Bayer reduz meta de sinergia da Monsanto para US $ 1,2 bilhão devido a desinvestimentos

Bayer said that combining with takeover target Monsanto will have positive synergy effects of about $1.2 billion on core earnings, less than the $1.5 billion initially targeted because more divestments were needed to get antitrust approval.

The German drugs and pesticides maker, which is holding its annual shareholder meeting on Friday, said in a statement that the targeted synergies will have their full effect on annual adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) from 2022.

Bayer Chief Executive Werner Baumann said he expects the transaction to be closed in the near future.

Reuters, 25/05/2018

Fonte Imagem: Reprodução